Literature DB >> 19861176

Expression of the AMACO (VWA2 protein) ortholog in zebrafish.

Jan M Gebauer1, Kristina Røkenes Karlsen, Wolfram F Neiss, Mats Paulsson, Raimund Wagener.   

Abstract

AMACO is a basement membrane associated protein that belongs to the VWA domain-containing protein superfamily. In addition to three VWA domains it contains two EGF-like domains, a cysteine-rich domain and a unique domain. Mouse AMACO has been partially characterized, but its function remains unknown. The zebrafish genome contains a single AMACO ortholog gene on chromosome 12. The domain structure is completely conserved between zebrafish and mouse and the first EGF-like domain, carrying a rare O-glucosylation and O-fucosylation consensus sequence, has the highest identity at the protein level. RT-PCR shows strongest AMACO expression during development, starting at the 5 somite stage. An antibody specific for zebrafish AMACO detected expression mainly in myosepta but also in skin, pronephros, pituitary gland, otic capsule and gills. In situ hybridization revealed that the muscle precursor cells of the somites express the protein that is laid down in the myosepta.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19861176     DOI: 10.1016/j.gep.2009.10.005

Source DB:  PubMed          Journal:  Gene Expr Patterns        ISSN: 1567-133X            Impact factor:   1.224


  2 in total

1.  AMACO is a component of the basement membrane-associated Fraser complex.

Authors:  Rebecca J Richardson; Jan M Gebauer; Jin-Li Zhang; Birgit Kobbe; Douglas R Keene; Kristina Røkenes Karlsen; Stefânia Richetti; Alexander P Wohl; Gerhard Sengle; Wolfram F Neiss; Mats Paulsson; Matthias Hammerschmidt; Raimund Wagener
Journal:  J Invest Dermatol       Date:  2013-11-14       Impact factor: 8.551

2.  Epigenetic and transcriptional dysregulation of VWA2 associated with a MYC-driven oncogenic program in colorectal cancer.

Authors:  Beatriz González; Ferran Fece de la Cruz; Johanna Kristina Samuelsson; Andreu Alibés; Sergio Alonso
Journal:  Sci Rep       Date:  2018-07-23       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.